Most people compare gummies and pills by taste, convenience, and what feels easier to take. That misses what matters when you're building a product that holds up. In manufacturing, gummies and pills are two different categories.
Gummies are a food-style system carrying supplement ingredients; tablets and capsules are precision dosage forms built for repeatability. That difference drives everything: how much you can put in a serving, how stable the formula will be, and what can go wrong during production. It also determines what you must test to release a compliant batch.
Potency drift over shelf life
A supplement can look perfect at release and still change over time. Heat, oxygen, humidity, and ingredient interactions all shift performance. That's dose (and quality) drift, and gummies and pills drift for different reasons.
Why gummies drift differently
Even a dry-feeling gummy is usually a semi-moist system compared to tablets or capsules. That changes stability and makes moisture control critical.
- Water activity (aW) influences how quickly ingredients degrade and how the gummy behaves physically. Keeping it below 0.6 limits microbial growth and helps retain actives like vitamin C.
- Moisture migration causes sweating, stickiness, crystallization, or hardening, changes that often accompany stability challenges.
- Package use matters: gummies are eaten more casually, so the container is opened frequently, exposing the product to humidity swings.
A well-manufactured gummy is engineered to stay within specification through end of shelf life. That means building a thorough stability plan, a packaging strategy matched to the formula, and realistic production controls. A stability plan pairs real-time testing at labeled storage conditions with accelerated testing at elevated temperature and humidity, commonly 40°C and 75% relative humidity, so shelf life can be projected before a full real-time study finishes.
How tablets and capsules drift
Tablets and capsules are typically lower-moisture systems, which makes long-term stability easier. But they come with their own issues, most of them mechanical and compatibility-driven.
- Compression forces (tablets) stress ingredients and impact how the final unit performs over time.
- Ingredient compatibility can become a long-term problem if reactive components aren't managed in the formula design.
- Moisture uptake in a powder blend alters disintegration behavior and consistency if packaging and storage are ignored.
Gummies drift mostly through the environment. Tablets and capsules drift mostly through mechanical stress and ingredient interactions. The goal is the same either way: consistent, repeatable quality.
Payload limits: what each format can hold
Think of each dosage form as a container with limits. The deciding question is what the format can hold without breaking the manufacturing process or the consumer experience.
Gummies are volume-limited
Gummies have a practical ceiling on how much material they can carry per piece before quality starts to slide. A standard gummy weighs about 3 to 4 grams, and most of that mass goes to the gel base, sweeteners, acids, and flavor, so the room left for actives is small. You can push the load, but the tradeoffs show up fast.
- Too much powder leads to grit and an unpleasant chew.
- Heavy solids interfere with gel structure, causing deformation, sticking, or inconsistent piece weights.
- Texture expectations are unforgiving: small changes are noticeable immediately.
In gummy development, success comes down to managing solids, texture, and uniformity as one system, not as separate problems.
Tablets and capsules are density-limited
Pills generally allow higher loads and more complex formulas, but you're still dealing with constraints, just different ones. A single capsule can carry 500 to 600 mg of a concentrated extract, which is why heavier per-serving doses usually land in pill form.
- Flowability must be consistent to ensure uniform fills (capsules) and uniform die feed (tablets).
- Compressibility becomes a make-or-break factor for tablet strength and performance.
- Consumer usability matters: oversized tablets and capsules become a practical barrier.
If the concept requires a heavier payload or a more complex blend, tablets and capsules are easier to engineer without sacrificing manufacturability.
Process risk: gummies are more sensitive than most teams expect
Once a tablet or capsule process is dialed in, it is repeatable. Gummies are more sensitive to process conditions and behave more like a controlled confectionery process than a basic mix and fill operation.
Small shifts create big changes in the final product: appearance, texture, and uniformity. The variables that matter most include:
- Cook profile (time and temperature), which affects final moisture and texture
- pH management and the timing of acid addition, which affects gel set and stability pathways
- Deposit temperature and mixing uniformity, which influence piece weights and consistency
- Cure conditions, which drive moisture equilibration and long-term chew
Gummy manufacturing success depends on operating inside a tight, validated process window.
Quality control: gummies often require a wider dashboard
QC priorities for gummies
- Water activity (aW) tracking for stability and overall risk management
- Moisture content for texture control and shelf-life consistency
- Piece weight and deposit accuracy to support serving consistency
- Uniformity verification, especially when using powdered actives or inclusions
- Texture/firmness as a practical indicator of moisture behavior over time
QC priorities for tablets and capsules
- Blend uniformity before compression or encapsulation
- Weight variation of the final dosage units
- Hardness and friability for tablets
- Disintegration/performance checks to confirm the unit behaves as intended
- Moisture management of the blend and packaged units
Gummies need more food-style controls layered on top of supplement analytical testing. Pills lean more on mechanical performance and pre-process uniformity controls.
Packaging isn't an afterthought, especially for gummies
In supplement manufacturing, packaging is sometimes an afterthought. For gummies, that's a mistake. The package functions like part of the formula: it controls the environment the product lives in.
Packaging pressure points for gummies
- Moisture and oxygen barriers reduce drift.
- Desiccant strategy requires balance: too aggressive and gummies toughen, too mild and you risk sweating and sticking.
- Heat exposure during distribution deforms gummies even when the formula looks stable on paper.
Packaging considerations for tablets and capsules
Tablets and capsules are more forgiving, but they're not immune. Hygroscopic formulas, odor-sensitive blends, and certain delivery designs require higher-barrier materials and thoughtful moisture control.
A manufacturer's checklist for choosing the right format
If you're deciding between gummies and pills, start by evaluating which set of variables you can control most reliably. These questions surface the real constraints.
- What is the target per-serving payload (mg)? Can it fit in a gummy without grit, sticking, or structural issues?
- How sensitive is the formula to moisture and oxygen? Which dosage form makes that easier to manage?
- Do we have a defined water activity target? (Not just moisture percentage.)
- What packaging system will be used? And how will it perform under real storage and shipping conditions?
- Which QC tests become necessary because of the chosen format?
- How will we verify end-of-shelf-life compliance? The goal is consistency through expiration, not just at release.
- How will typical consumer use affect the product? Frequent opening/closing matters more than most teams expect.
What each format costs to make
Format choice is a cost decision as much as a formulation decision. Gummies add process steps that tablets and capsules do not: the batch is cooked, deposited, cooled, and cured, and each step has to hold inside a validated window. Gummies also carry a longer QC list and heavier packaging with barrier films and desiccants.
Those requirements show up in unit economics. Published contract manufacturing cost tables put gummies at roughly $3 to $8 per finished bottle, against $1.50 to $4 for capsules and tablets, and gummy minimum order quantities typically run several times higher. That changes working capital and inventory risk, not just the per-unit price. None of this makes gummies the wrong choice. It makes cost per unit part of the format decision, alongside the payload and stability questions above.
Making the decision
Gummies and pills are two different manufacturing strategies. Gummies win on consumer experience, but demand tight control of moisture behavior, process sensitivity, and packaging performance. Tablets and capsules win on payload flexibility and physical stability, but require disciplined control of blend uniformity, compression and encapsulation variables, and ingredient compatibility.
The best choice is the dosage form you can manufacture consistently, test appropriately, and protect with the right packaging, so the product stays within spec from the first unit to the last day of shelf life.